Ted Rogers Understanding of Exacerbations in Heart Failure 2: Monitor
NCT07447908
Summary
Heart Failure (HF) is a complex disease associated with the highest burden of cost to the healthcare system. The cardiopulmonary exercise test (CPET) is instrumental in determining the prognosis of patients with HF. This multicentre study will validate whether aggregate biometric data from the Apple Watch combined with demographic, cardiac, and biomarker testing can improve our ability to predict heart failure outcomes among a diverse outpatient HF population.
Eligibility
Inclusion Criteria: * broad age range (\> 18 years of age) * NT-proBNP \> 400 or 1000 if in AF * Within 3 months post discharge from HF hospitalization/ HF ED visit/ HF rapid clinic visit with intensification of diuretic therapy * NYHA functional class I-IV, heart failure with reduced and preserved ejection fraction * Literacy in English * Patient provided informed consent Exclusion Criteria: * Unable to perform a CPET based on the standard protocol * End stage renal disease requiring dialysis * Living with LVAD * MRP deems patient unfit for the study * Post heart transplant
Conditions6
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT07447908